Lori McNeill

Insider Reports History

Entity
Individual
Location
C/O Sonnet Biotherapeutics Holdings, Inc, 100 Overlook Center, Suite 102, Princeton, NJ
Signature
/s/ John Harry Cross III, power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lori McNeill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sonnet BioTherapeutics Holdings, Inc. Director Common Stock 394 $276 $0.70 Dec 11, 2023 Direct

Insider Reports Filed by Lori McNeill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 11, 2023 1 $0 4 Dec 5, 2024 Director
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 14, 2022 1 $0 4 Dec 22, 2022 Director
SONN Sonnet BioTherapeutics Holdings, Inc. Sep 25, 2022 0 $0 3 Oct 4, 2022 Director